Issued Patents All Time
Showing 1–25 of 52 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12129248 | Chromobox protein inhibitors and uses thereof | Jun Qi, Alexander Federation, Zoe Jacobson, Anthony Varca | 2024-10-29 |
| 11999802 | Compositions and methods for selective protein degradation | Andrei Golosov, Carleton Proctor Goold, Carla Guimaraes, Marc Horst Peter Hild, Gregory Motz +4 more | 2024-06-04 |
| 11944625 | Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies | Jun Qi, Dennis Buckley, Leonard I. Zon, Elizabeth MACARI | 2024-04-02 |
| 11845728 | Compounds and methods for treating cancer | Michael Erb, Jun Qi | 2023-12-19 |
| 11666580 | Mechanism of resistance to bet bromodomain inhibitors | Kornelia Polyak, Shaokun Shu, Charles Y. Lin | 2023-06-06 |
| 11578075 | Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use | Dennis Buckley, Mette Ishoey ROSENBAUM, Georg Winter | 2023-02-14 |
| 11446309 | Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors | Michael R. McKeown, Margaret A. Shipp, Bjoern Chapuy, Kwok-Kin Wong, Zhao Chen | 2022-09-20 |
| 11406645 | Acetamide thienotriazolodiazepines and uses thereof | Jun Qi, Minoru Tanaka | 2022-08-09 |
| 11306105 | Cyano thienotriazolodiazepines and uses thereof | Jun Qi, Minoru Tanaka, Dennis Buckley | 2022-04-19 |
| 11236082 | EZH2 inhibitors and uses thereof | Jun Qi, Kwok-Kin Wong | 2022-02-01 |
| 10980808 | Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies | Jun Qi, Dennis Buckley, Leonard I. Zon, Elizabeth MACARI | 2021-04-20 |
| 10934256 | Compounds and methods for treating cancer | Michael Erb, Jun Qi | 2021-03-02 |
| 10913752 | Bivalent bromodomain inhibitors and uses thereof | Jun Qi, Minoru Tanaka, Justin Roberts | 2021-02-09 |
| 10881668 | Acetamide thienotriazolodiazepines and uses thereof | Jun Qi, Minoru Tanaka | 2021-01-05 |
| 10813939 | Bromodomain inhibitor as adjuvant in cancer immunotherapy | Eduardo M. Sotomayor, Jianguo Tao | 2020-10-27 |
| 10793571 | Uses of diazepane derivatives | Nathanael S. Gray, Jun Qi, Michael R. McKeown, Dennis Buckley | 2020-10-06 |
| 10730860 | Diaminopyrimidine benzenesulfone derivatives and uses thereof | Jun Qi, Minoru Tanaka | 2020-08-04 |
| 10676504 | Method for preparing largazole analogs and uses thereof | Robert M. Williams, Dane Clausen, Olaf G. Wiest, Tenaya Newkirk, Albert Bowers +1 more | 2020-06-09 |
| 10676484 | Compositions and methods for treating leukemia | Johannes Zuber, Junwei Shi, Christopher R. Vakoc, Scott W. Lowe, Constantine S. Mitsiades | 2020-06-09 |
| 10669253 | Methods to induce targeted protein degradation through bifunctional molecules | Dennis Buckley, Georg Winter | 2020-06-02 |
| 10633371 | EZH2 inhibitors and uses thereof | Joshiawa Paulk, Jun Qi | 2020-04-28 |
| 10538534 | Synthesis and utility of new capgroup largazole analogs | Robert M. Williams, Dane Clausen, Olaf G. Wiest, Le Zhao, Christine Elizabeth Dunne | 2020-01-21 |
| 10525139 | Folate-conjugated molecules for delivery of toxic small molecule inhibitors to cancer cells and methods of use | Kimberly Stegmaier, Jun Qi, Anthony Varca, Giovanni Roti | 2020-01-07 |
| 10464897 | Compounds and methods for treating cancer | Michael Erb, Jun Qi | 2019-11-05 |
| 10464925 | Methods to induce targeted protein degradation through bifunctional molecules | Dennis Buckley, Georg Winter | 2019-11-05 |